The discovery of promising targets for anticancer drug development has emerged with many potential enzymes. Among these, the aurora family of kinases has become a very lucrative target with some potential inhibitors in its arsenal. Recent findings show that targeting aurora B itself is sufficient to exhibit anticancer activity. When compared with other anticancer targets, aurora B has a very limited number of specific inhibitors. Recently GSK1070916 and reversine were discovered as promising new aurora B inhibitors. Amongst these GSK1070916 emerged as the most potent molecule targeting aurora B. Taking the scaffold of GSK1070916 as a reference, new molecules were designed by isosteric/bioisosteric and fragment based modifications. Furthermore, an accurate cross-platform docking, MM/GBSA based rescoring, molecular dynamics simulation were carried out to compare the binding conformation and affinities of the designed molecules with the references. Top two designed molecules showed better docking score and a better binding free energy profile as compared to reversine and GSK1070916 with the best ligand retaining conserved hydrogen bond and salt bridge interactions with Ala173, Ala233 and Lys122. The binding mode of top two designed ligands is relatively similar to that of reversine and GSK1070916. Molecular dynamics simulations proved that the identified hits are rather stable in the enzyme active site pocket, which further confirms the potential of the designed ligands as a specific target for aurora B.
INTRODUCTION
The aurora family of serine/threonine kinases regulates the process of mitosis and thus emerged as a potential target for anti-cancer drug development. Human aurora kinase are structurally and functionally classified into three different subtypes, aurora A, B and C [1, 2] . The name "aurora kinase" was given because the poles of the mitotic spindles screened from Drosophila mutations bear a resemblance to the pattern of "Aurora Borealis" [3] . Recently aurora A and B emerged as a promising drug target for development of novel anticancer agents because of their prominent role in cell cycle. Aurora A plays an essential role in microtubules formation, centrosomal maturation and separation while aurora B plays a prominent role in cytokinesis. The role of aurora C is not well understood but it is believed that the role *Address correspondence to this author at the Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban 4001, South Africa; Tel: +27 0312607413; Fax: +27 031 260 779; E-mail: soliman@ukzn.ac.za # These authors contributed equally of aurora C compliments the function of aurora B. Aurora A and B are over expressed in a set of diverse of solid tumors including those associated with colon, breast, prostate, pancreas etc. Over expression and inhibition of aurora B leads to metastasis and apoptosis respectively [4, 5] .
Recent studies show that inhibition of aurora B itself is sufficient for anti-tumor activity [1] . A number of small molecule inhibitors were reported as potential drug-like molecule targeting specially aurora kinases [2] . Amongst those, GSK1070916 and reversine were reported as promising candidates targeting aurora B [6] . Both of these molecules act as a reversible ATP-competitive inhibitor-targeting ATP binding pocket of aurora B [6, 7] . The crystal structure of reversine-aurora B complex gives an evidence to the ATP binding pocket of reversine which provides an insight into binding conformation, ATP-competitive mechanism of reversine as well as structurally similar molecules such as GSK1070916 [8] .
Various in silico approaches such as, molecular docking, fragment-based drug design and virtual screening are being widely used to identify potential drug-like molecules against different targets [9] [10] [11] [12] [13] . In this report, using virtual screening tools, MM/GBSA based rescoring novel GSK1070916 analogs were screened in order to identify potential lead molecules targeting aurora-B. The stability and binding conformation of the top ranked compound was compared with one of the previously reported inhibitor bound aurora B crystal structure in order to get mechanistical insight of ligand binding. The comprehensive findings reported in this study e.g. fragment replacement, cross platform docking; MM/GBSA based rescoring, molecular dynamics simulation will prove helpful in future efforts in designing selective aurora B inhibitors.
COMPUTATIONAL METHODOLOGY
The computational procedure adopted in this study is depicted in Fig. (1) .
Protein Preparation
The crystal structure of aurora B in complex with reversine was retrieved from protein data bank (PDB: 2VGO) and used for subsequent computational calculations [7] . Chain A of the protein has been removed as the inhibitor reversine reserves all-important interactions were preserved with chain B. The inhibitor reversine and other non-standard residues were deleted from the protein keeping co-ordinates intact for further docking analysis.
Designing of Novel Leads as Potential Aurora B Inhibitors
Isosteric/bioisosteric and fragment inspired molecular modifications proved as a useful strategy to design potential new leads in drug design [14] . In this study the structure of GSK1070916 ( Fig. 2A) was taken as a core structure to design a library of 25 new lead compounds (structure of all compounds are available in Supplementary Materials) using isosteric/bioisosteric modifications as well as including fragments from reversine ( Fig. 2B and C, respectively) .
Molecular Docking
It is widely known that docking calculations, in many cases, could produce unreliable or misleading results [15] . Though, implementing some tools to the conventional protocols could enhance docking results. For instances, "loopdocking", which was developed in-house, has proved to improve the docking results [16, 17] . In this study we used a hybrid loop-docking/cross-docking protocol to ensure enhanced ranking of the screened compounds. In this hybrid docking protocol, we first screened all the modeled compounds including reference molecules, GSK1070916 and reversine against aurora B by loop-docking protocol using Autodock Vina [16, 17] . The top ten-ranked compounds (based on binding affinity) from the protocol with reference GSK1070916 and reversine were then subjected to extraprecision cross docking and post-docking analysis using GLIDE module of Schrodinger's small molecule drug discovery suite. This loop docking/cross-docking protocol enhances the identification of specific potent ligands and also narrows down the false hit.
Before docking calculations, all the designed ligands together with the reference molecules were minimized using MMFF94s force field and steepest descent algorithm using Avogadro [18] . Reversine was extracted from the bound complex (PDB: 2VGO) and used as it is for docking purpose using Autodock Vina [19] . The key amino acids interacting with reversine identified from protein data bank was used to define the grid box setting the exhaustiveness at 8. All ligands and proteins were converted to pdbqt format using Raccoon module integrated with MGL tools [9] . For initial validation of our docking protocol, we docked reversine into the active site of aurora B (PBD code: 2VGO) and the root of mean square deviation (RMSD) between crystal structure and docked complex was found to be ~0.003Å, which indicates that docking approach is, to high extent, reproducible and reliable. All the docked poses have been visualized using ViewDock plugin in Chimera (Fig. 3) [20] .
For further precision, the top-ten docked ligands from the first docking run (using Autodock Vina binding energy) Fig. (1) . The computational workflow adopted in this study. Fig. (2) . 2D representations of GSK1070916 (A) and Reversine (B) respectively. A= green highlighting positions used for modifications; B= yellow highlighting the fragment of reversine used in designing new leads; C= key fragments used for structure modification, R= attachment point to the core scaffold.
were subjected to further docking using GLIDE. GLIDE was proved to produce highly reliable results based on a recent report showing comparative analysis of different docking softwares [20] [21] [22] [23] .
Prior to docking using GLIDE the protein structure was prepared using multistep process of protein preparation wizard using Maestro's GUI interface [23, 24] . The systems were then minimized using OPLS-2005 force field with implicit solvation [25] . All designed ligands have been prepared using the LigPrep module integrated with Schrodinger [26] . The prepared ligands and protein were subjected to extra precision (XP Docking) using Glidemodule viaMaestro interface [26] .Glide docking uses a systematic sampling approach, which takes into account ligand's position, conformation and orientation before evaluating the energy profiles between the ligand-protein interactions. GLIDE uses Gscore to rank the docked complexes based on the following equation [21, 22] . The docked complexes were ranked using GLIDE's Gscore and top-two docked complexes based on Gscore were subjected to molecular dynamics, MM/GBSA based rescoring and post dynamics analysis to gain an insight into stability, binding and beyond.
As stated above, docking results could be artifacts. To ensure that the docked complexes are stable enough over a reasonable time scale, molecular dynamics simulations as well as post dynamics analysis [27] were performed on the top-ranked compounds. MM/GBSA based rescoring was used as an effective tool to rank the top ranked ligands based on their relative free energy, which often correponds to the outcome of biological evaluation.
Molecular Dynamics (MD) Simulation
The two top-ranked ligands, GSK1070916 and reversine in complex with aurora-B was subjected to an all-atom molecular dynamics simulation using GPU version of PMEMD engine provide with Amber12. The details parameters to perform the molecular dynamics simulation were described in details by Bhakat et al. [28] . The ligands were extratcted from their bound conformation and parametrized using GAFF force-field integrated with Amber 12. Whereas, the protein structure was defined by FF99SB variant of amber force field. The Leap module integrated with Amber 12 was used to create complex immersed in a waterbox of 10 Å surrounded by TIP3P water molecules. The missing residues and hydrogen atoms were added and counter ions were placed to neutralize the systems. All systems were then subjected to a rigorous process of minimization, heating and equilibration as described by Bhakat et al. The systems were subjected to a 30ns production run in a NPT ensemble with a target pressure set at 1 bar and coupling constant of 2fs. The trajectories were saved in every 1ps and analyzed using PTRAJ and CPPTRAJ modules [29] integrated with Amber 12. All visulaisations were carried out using VMD, Chimera and Maestro's GUI interface.
MM/GBSA Binding Free Energy Calculation
Post dynamics MM/GBSA proved as a useful method to screen docked complexes based on their relative binding free energy [30, 31] . MM/GBSA calculations were avergaed over 1000 snapshots with an interval of 30 ps from a 30ns production run. MM/GBSA based calculation is a thermodynamic endpoint calculation which gives valuable insights into association and also highly corresponds to the biological activity in a greater extent. The following set of equations give a detailed explanation of the calculation of binding free energy:
The detailed explanation of these parameters were reported by Bhakat et al. in a recent report.
Residue Interaction Networks (RIN) analysis
The averaged MD structures of GSK_LIG6 and reversine complexed with aurora B were used to construct RIN profile as described by Bhakat et al. [11] . RIN is a key strategy to monitor structural change in protein backbone during biomolecular process. The RIN profiles were generated using RING server and further analyzed using RINanalyzer plugin integrated with Cytoscape. In a RIN profile the nodes correspond to backbone amino acids where, the edges correspond to different inter residue contact details.
Molecular Properties and ADME Profile Prediction:
Molecular properties and ADME parameters of top ranked ligands as well as template GSK1070916were predicted using Schrodinger's Qikprop module.
RESULTS AND DISCUSSIONS

Molecular Docking and Virtual Screening
The designed ligands based on isosteric/bioisosteric modification and fragment replacements with reference ligands (GSK1070916 and reversine) were subjected to a first run of "loop-docking" calculations using Autodock Vina to rank them according to the binding affinities. The top ten compounds (based on binding affinities) with reference molecules were then subjected to additional precision docking calculations (cross-docking) using Glide to enhance docking results and remove false hits. Based on "Glide GScore", it was found that the modeled compound GSK_LIG6 showed better binding affinity towards aurora B when compared against GSK1070916 and reversine. Yet GSK_LIG23 also showed better GScore than GSK1070916 but slightly lower (by ~ 0.07) than reversine. Interestingly, it was found that the two top-ranked designed ligands formed four hydrogen bonds while reversine and GSK1070916 both formed three hydrogen bonds with the aurora B active site residues ( Table 1) . Also it was observed the top-ranked ligands occupied, to a great extent, the same binding space and exhibited similar binding orientation in the active site as of reversine (Fig. 4) -as evident from the superimposition of GSK_LIG6 complex against reversine-aurora B complex (RSMD ~ 0.018 Å) (Fig. 5). 
MM/GBSA Based Rescoring
Molecular docking calculation can often lead to identification of false positives. Post-dynamics MM/GBSA based rescoring came as an effective tool to re-rank the docked complexes according to their relative binding free energy. The binding free energy profile of top two docked compounds, GSK1070916 and reversine unveiled an interesting co-relation. The difference in binding free energy between reversine and GSK1070916 was found to be ~ 3 kcal/mol, which corresponds to the fact that GSK1070916 was much potent than reversine. Further it was observed that the Fig. (4) . Superimposition of GSK_LIG6, GSK_LIG23, reversine and GSK1070916 complexes with aurora B, highlights almost similar binding mode in the active site. (A= showing solvent accessible surface area of the complex, B= zoomed view) All important amino acid residues involved in interaction has been highlighted in green. (Red=GSK_LIG6, Blue=reversine, Magenta =GSK_LIG23 and Cyan= GSK1070916). The surface representation was done as per hydrophobicity of different residues defined by Chimera.
Fig. (5).
Binding mode of GSK_LIG6 (red) and reversine (blue) in the active site of aurora B. Amino acid residues involved in crucial interactions are highlighted in green. difference in binding free energy between GSK_LIG6 and GSK1070916 was ~7 kcal/mol which signifies a better binding between GSK_LIG6 and aurora B. Interestingly, it was observed that GSK_LIG23 possessed similar binding free energy profile (~ 1 kcal/mol) with that of GSK1070916. These differences in binding free energy further give credibility to the fact that these designed ligands can be explored as possible lead candidate in future discovery process. Further, analysis of binding free energy profile revealed that the van-der Waals contribution was the main driving force behind the total binding free energy, which was evident from high vdW values in case both MM/GBSA rescoring and perresidue energy profile ( Table 2 , Fig. 6 and Fig. 7) . The MM/GBSA profile of top ranked ligands in comparison with GSK1070916 and reversine not only provides more reliable evidence of their potency but also gives insight into residuebased contributions towards binding that will be crucial in future drug discovery process.
Ligand Interaction
Molecular docking results showed that GSK_LIG6 and reversine form conservative hydrogen bond interactions with Ala173. However, GSK_LIG6 forms other two hydrogen bonds with Gln145.Reversine shows a hydrogen bond interaction with Glu171. It is also interesting to notice that GSK_LIG6 forms a salt bridge interaction with Lys122. Results showed that GSK_LIG6 occupies a place between Arg97 and Gly236 whereas reversine occupies a comparatively smaller binding space between Arg97 and Leu223 (Fig. 8) . A 30ns molecular dynamics simulation revealed that there is a reserved key hydrogen bond interaction between reservine and Ala173 and Glu171. Whereas, in case of GSK_LIG6 the hydrogen bond interaction with Ala173 and salt bridge interaction with Lys122 retained after molecular dynamics simulation whereas the hydrogen bond interaction with Gln145 changes to hydrogen bond interaction with Ala233 (Fig. 8). 
Insight from Molecular Dynamics
To gain insight into the stability and dynamics of protein ligand complexes, 30ns MD simulations were performed using the GPU version of Amber 12. Post-dynamics analysis showed that backbone of both GSK_LIG6 and reversine protein complexes exhibited RMSD below ~ 2.8Å over the entire MD trajectory, which indicates that both docked complexes are relatively stable over MD simulations (Fig. S1 and S3 in Supplementary Materials). Further it was observed that the backbone C-alpha fluctuation as well as potential energy profile ( Fig. S2 and S4 respectively) of both these ligands were well converged during the simulation. This further leads to the credibility that the ligand bound conformation in both cases was well stabilized for further calculations.
The root mean square fluctuations (RMSF) of the protein backbone in complex with GSK_LIG6 and reversine have been monitored over the 5 ns MD trajectory. As indicated above, residues 97-235 showed to play a prominent role in ligand-protein interactions, therefore, the RMSF of this region is plotted (Fig. 9) . As shown in the RMSF plot (Fig. 9) , in case of GSK_LIG6, residues 103, 111, 114, 115, 16, 121, 163, 167, 169, 175-180,191,208,214,230 fluctuates more when compared to reversine protein complex. Residue number lys122, which formed crucial ionic interaction with the nitrogen atom of the GSK_LIG6 (Fig. 9) fluctuates more in case of reversine-protein complex when compared with GSK_LIG6-protein complex.
The ligand protein contact map and per-residue interaction fraction plots were monitored throughout the simulation for GSK_LIG6 and reversine protein complexes. In case of reversine aurora B complex, it was observed that Ala173 contributed the most towards the binding with 81% via hydrogen bond interactions with the -NH part and62% via hydrogen bond interaction with one of the nitrogen atom of the pyridine nucleus and a small water bridge contribution with reversine whereas, Glu171 contributed 99% via hydrogen bond interaction with reversine during simulation period. This serves as a prominent evidence of stable hydrogen bonds between Ala173 and Glu171 with reversine, which makes these residues key residues in the reversine-aurora B complex ( Fig. 8 and 10) . In case of GSK_LIG6 and aurora B complex it has been observed that the Ala173 hydrogen bond interaction stays during both pre-dynamics and postdynamics simulation process. Ala173 forms two hydrogen Fig. (7) . Per-residue footprint of reversine complexed with aurora B.
Fig. (8).
Pre and post dynamics ligand interaction maps of reversine and GSK_LIG6. Pre-dynamics ligand interaction map of reversine (A) and GSK_LIG6 (C) and post-dynamics ligand interaction map of reversine (B) and GSK_LIG6 (D) highlights important residues and % interaction contribution during simulation time. Fig. (9) . The RMSF fluctuation of GSK_LIG6 and reversine highlighting the residues ranging from 97 to 235 as these residues played crucial role during docking and post dynamics ligand protein interaction. Fig. (10) . Protein-Ligand contact map with per-residue interaction fraction of GSK_LIG6 and reversine with target enzyme during 5ns simulation. A and C=reversine; B and D= GSK_LIG6.
bond interactions with GSK_LIG6 with 85% and 98% contribution respectively during the whole simulation period, whereas Lys122 formed a stable salt bridge with GSK_LIG6 via 98% contribution during simulation period. It has also been observed that Ala233 formed hydrogen bond interaction with GSK_LIG6 via 96% contribution during simulation period (Fig. 5) . These findings are evident from the darker stripes and stacked bar charts of protein-ligand contacts during the simulation period (Fig. 10's C & D) .
Network Analysis
The network analysis of the protein backbone is a new strategy to identify key residue interactions between differ-ent amino acids to monitor the difference in amino acid interactions during protein-ligand binding [32] . In this work we investigated the interaction network by focusing on key amino acid residues of the GSK_LIG6 and reversine in complex with aurora B by generating (RIN) using the representative docked complexes. Though the overall network containing the backbone of the protein-ligand complexes are somehow different but a deep interaction analysis is always necessary to understand changes in networks. Often during molecular dynamics simulation or attachment of inhibitor changes the connection between residues in protein network. RIN provides a visual interface to check the stability of residue-residue connection as well as understanding of different forces responsible in connection among crucial residues. A detailed network interaction analysis has been carried out on Ala173 and Glu171 of reversine-protein complex and compared with GSK_LIG6-protein complex and the same approach has been adapted to carry out the network analysis of Ala173, Lys122 and Ala233 as all these residues plays an important role ligand binding ( Fig. S5 and S6 of Supplementary Materials). No difference in residue-residue connection was found in both these cases, which further proved the stability of the enzyme backbone during the process of simulation as well as gives insight into residue-residue connection among crucial residues of aurora B active site.
ADME and Drug-likeness Prediction
The ADME and drug-like properties of all our designed GSK analogs have been calculated in comparison with GSK1070916 ( Table 3) . It has been observed that though all the ADME properties of our designed ligands are well within the acceptable range. The ADME properties of both our designed ligands have been relatively similar that of GSK1070916. Though the in-silico profile of our designed molecules are somehow similar to GSK1070916 but still designing of molecules with excellent ADME parameters with preferably high % human oral absorption.
From all these results it has been observed that designed GSK1070916 analogs by making no changes in the core fused pyrrole and imidazole scaffold and isosteric/bioisosteric and knowledge based side chains and fragment attachment came up with two very potential lead molecules with favorable drug-like profile which can emerge as a potential drug molecule in further development (Fig. 11) . It is very interesting to notice crucial Ala173 interaction stayed intact in both reversine and GSK_LIG6. Also incorporation of an isosteric SO 2 group instead of CO 2 emerged with an extra hydrogen bond and salt bridge interaction in case of GSK_LIG6, which might be the reason of its better binding free energy than GSK1070916. It was also noticed that attachment of the morpholine fragment from reversine with a -CH 2 linker to the scaffold of GSK1070916 increased the charged interactions with the amino acids from binding pocket. Both these designed ligands showed better Glide GScore and binding free energy profile than two existing aurora B inhibitors, which make these two potential strong candidates for further development. Designing strategy and fragments used in designing these ligands may serve as important fragments for further designing of better inhibitors targeting aurora B (Fig. 2, 11 ).
CONCLUSION
By validated loop docking/cross docking approach, MM/GBSA based rescoring and molecular dynamics simulation we identified some potential new inhibitors towards aurora B. The designed ligands, based on the knowledge of isosteric/bioisosteric replacements and fragment joining in combination with an integrated loop docking/cross docking and molecular dynamics simulation, have come up with two very potential ligands with a respective ADME and drug-like profile when compared with GSK1070916. Furthermore, a detailed post dynamics analysis on ligand-protein complexes proved that the active site of aurora B can accommodate slightly larger molecule than reversine and similar to that of GSK1070916. It was also observed that the amino acid residues ranging from 97 to 236 accommodate all two top designed ligands GSK_LIG6, GSK_LIG23 as well as GSK1070916 and reversine. Further, it was observed that Ala173, Lys122, Gln145, Glu171, Ala233 played an important role in binding especially the hydrogen bond interaction between Ala173 and pyrrole ring of GSK_LIG6, GSK_LIG23 and reversine plays a very prominent role in overall binding of the ligands. Interestingly, the fragments we used in designing of our analogs emerged with molecules having better binding free energy profile, as compared to GSK1070916, which indicates its future use in designing more potent aurora B inhibitors. Two of our top ranked ligands bind around the same cavity of aurora B with almost similar binding mode that of reversine. As anticancer research gaining its momentum with different emerging targets and drug molecules we believe that our designed molecules, fragments and findings will be useful in designing better aurora B specific molecules as well as broad-spectrum molecules targeting aurora family of kinases, which in future can emerge as potential drug candidates. The loop docking/cross docking approach, binding modes, binding free energy estimation, identification of crucial amino acid interactions as well as backbone network analysis carried out in this study will proved to be cornerstone in designing better drug-like molecules with high specificity towards aurora family.
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